Sanaz Safaei
Overview
Explore the profile of Sanaz Safaei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haghpanah S, Zekavat O, Safaei S, Ashraf M, Parand S, Ashraf H
BMC Ophthalmol
. 2022 Jun;
22(1):279.
PMID: 35751049
Background: Structural ophthalmologic findings have been reported in patients with β-thalassemia due to chronic anemia, iron overload, and iron chelation therapy toxicity in few previous studies. We aimed to investigate...
2.
Haghpanah S, Asmarian N, Zekavat O, Bordbar M, Karimi M, Zareifar S, et al.
Spat Spatiotemporal Epidemiol
. 2021 Jan;
36:100389.
PMID: 33509421
Background: Using maps and spatial analysis are technologies to evaluate the magnitude and spatial distribution of disease in epidemiology investigations. We aimed to conduct a Bayesian spatial analysis on epidemiologic...
3.
Haghpanah S, Cohan N, Bordbar M, Bazrafshan A, Karimi M, Zareifar S, et al.
Ann Hematol
. 2020 Nov;
100(3):635-644.
PMID: 33216196
Oxidative stress is a major mechanism contributing to the progression of β-thalassemia. To assess the effect of vitamin E and N-acetyl cysteine (NAC) as antioxidant agents on total oxidative stress...
4.
Haghpanah S, Zekavat O, Bordbar M, Karimi M, Zareifar S, Safaei S, et al.
BMC Ophthalmol
. 2020 Sep;
20(1):376.
PMID: 32962679
Background: Ocular involvement may occur via several mechanisms in patients with transfusion-dependent β-thalassemia (TDT) mainly chronic anemia, iron overload and iron chelator toxicity. We aimed to evaluate the frequency of...
5.
Safaei S, Abedi H, Parand S, Karimi M
Hemoglobin
. 2019 Aug;
43(3):198-203.
PMID: 31422722
β-Thalassemia (β-thal) is a chronic illness and its complications make the patient less compliant with the treatment protocol. This study aimed to evaluate the effect of a support-training system of...
6.
Karimi M, Haghpanah S, Pishdad P, Zahedi Z, Parand S, Safaei S
Ann Hematol
. 2019 Aug;
98(10):2267-2271.
PMID: 31388698
Silent brain lesions might be associated with overt cerebrovascular accident over time in beta thalassemia major (BTM) and intermediate (BTI). Aspirin may be protective in these patients. We evaluated brain...
7.
Bordbar M, Pasalar M, Safaei S, Kamfiroozi R, Zareifar S, Zekavat O, et al.
J Tradit Complement Med
. 2018 Jan;
8(1):141-146.
PMID: 29322002
This study aimed to determine the frequency and pattern of complementary and alternative medicine (CAM) use in thalassemia patients in south of Iran. The survey was done using a validated...
8.
Seyedifar M, Dorkoosh F, Hamidieh A, Naderi M, Karami H, Karimi M, et al.
Int J Hematol Oncol Stem Cell Res
. 2016 Dec;
10(4):224-231.
PMID: 27928477
Thalassemia is a chronic, inherited blood disorder, which in its most severe form, causes life-threatening anemia. Thalassemia patients not only engage with difficulties of blood transfusion and iron chelating therapy...
9.
Haghpanah S, Esmaeilzadeh M, Honar N, Hassani F, Dehbozorgian J, Rezaei N, et al.
Iran Red Crescent Med J
. 2015 Oct;
17(7):e28343.
PMID: 26421179
Background: Hepcidin is a key regulator of iron absorption in humans. It is mainly affected by hypoxia and iron stores. Objectives: The current study aimed to determine the correlation between...
10.
Rajaeefard A, Hajipour M, Tabatabaee H, Hassanzadeh J, Rezaeian S, Moradi Z, et al.
Epidemiol Health
. 2015 Jul;
37:e2015031.
PMID: 26212506
Objectives: The survival rate of thalassemia patients has not been conclusively established, and the factors associated with survival remain unclear. This study aimed to determine the survival rate of thalassemia...